期刊文献+

子宫内膜癌耐药细胞B-MD-C1(ADR^(+/+))与非耐药细胞B-MD-C1的蛋白质差异研究

Identification of differentially expressed proteins in B-MD-C1(ADR^(+/+)) and B-MD-C1 by proteomics
暂未订购
导出
摘要 目的:比较子宫内膜癌耐药细胞B-MD-C1(ADR^(+/+))与非耐药细胞B-MD-C1的蛋白质表达谱,识别和鉴定差异表达蛋白,分析差异蛋白与其耐药的关系。方法:采用双向凝胶电泳及基质辅助激光解吸电离-飞行时间质谱法对B-MD-C1(ADR^(+/+))与BMD-C1细胞进行蛋白质分离和表达谱研究,利用生物信息学方法鉴定差异蛋白质。结果:B-MD-C1细胞与B-MD-C1(ADR^(+/+))相比,蛋白质表达差异>2倍的蛋白质点有35个,其中18个蛋白点表达上调,17个蛋白点表达下调。应用Mascot软件查询Swiss-prot数据库初步鉴定差异表达的蛋白质点24个,这些蛋白质可能是B-MD-C1细胞产生耐药的相关蛋白,包括细胞骨架蛋白、代谢酶类、细胞周期相关蛋白、信号转导和凋亡调控相关蛋白、蛋白合成和参与糖酵解的蛋白等。结论:热休克蛋白、β-微管蛋白、丙酮酸激酶同工酶、核糖体蛋白等是B-MD-C1(ADR^(+/+))与B-MD-C1细胞间的差异蛋白,这些蛋白多与B-MD-C1(ADR^(+/+))细胞耐药密切相关。 OBJECTIVE:Multidrug resistance(MDR) is a major obstacle for effective treatment of tumors. Previous studies of MDR tended to concentrate in a single or a few related genes and their protein products.We focused on the total protein with the method of proteomics.The aim of this study was to investigate differently expressed protein in BMD -C1 and B-MD-C 1(ADR^(+/+)) cells by proteomic analysis.METHODS:The holoproteins of human carcinoma of endometrium cell lines B-MD-C1 and B-MD-C1(ADR^(+/+)) were measured by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization time-of-flight mass spectrometry(MALDI-TOF-MS).RESULTS:Thirty-five differential proteins were analyzed by peptide mass fingerprinting.The differentially expressed proteins could be divided into six groups based on their functions:molecular chaperones,cystoskeleton proteins(actin-related protein 3,lamin-B1 and tubulin beta chain),metabolic enzymes(78 kDa glucose-regulated protein,retinal dehydrogenase),proteins associated with cell cycle(eukaryotic initiation factor 4A-Ⅲ),proteins associated with cell proliferation,differentiation and apoptosis(endoplasmic reticulum protein,endoplasmic reticulum protein),and proteins associated with carbohydrate metabolism(60S acidic ribosomal protein,alpha-enolase).CONCLUSION:These differentially expressed proteins provided some clues to the mechanism of tumor cell resistant to cisplatin,providing the basis of searching for potential target of carcinoma.
出处 《癌变·畸变·突变》 CAS CSCD 2011年第4期263-268,共6页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 河北省普通高校强势特色学科资助项目(冀教高[2005]52) 河北省自然科学基金资助项目(C2009001195)
关键词 子宫内膜癌 蛋白质组学 多药耐药性 质谱分析 carcinoma of endometrium comparative proteomics multidrugs resistance mass spectrometry analysis
  • 相关文献

参考文献13

  • 1Jemal A, Thomas A, Murray T, et al. Cance statistics, 2002 [J]. CA Cancer J Clin, 2002, 52 (1): 23-47.
  • 2Elit L, Hirte H. Current status and future innovations of hormonal agents chemotheraphy andinvestigation alagents in endometrial cancer[J]. Cur Opin Obstet Gyneeol, 2002, 14 (1): 67-73.
  • 3Paron I, DE lia, Dambrosio C, et al. A proteomic approach to identify early molecular targets of oxidative stress in human epithelial lenscells[J]. BiochemJ, 2004, 78(38): 929-937.
  • 4Seevaratnam R, Patel BP, Hamadeh MJ. Comparison of total protein concentration in skeletal muscle as measured by the Bradford and Lowry assays [J]. J Biochem, 2009, 145 (6): 791-797.
  • 5Petraccia L, Onori P, Sferra R, et al. MDR(multidrug resistance) in hepatocarcinoma clinical-therapeutic implications [J]. Clin Ther, 2003, 154(5): 325-235.
  • 6Urbani A, Poland J, Bemardini S, et al. A proteomic investigation into etoposide ehemo-resistance of neuroblastoma cell lines[J]. Proteomics, 2005, 5(3): 796-804.
  • 7Liu Y, Liu H, Han B, et al. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis[J]. Cancer Res, 2006, 66 (6) : 3248-3255.
  • 8Galletti E, Magnani M, Renzulli ML, et al. Paclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanes[J]. Chem Med Chem, 2007, 2 (7) : 920-942.
  • 9Hathurusinghe HR, Goonetilleke KS, Siriwardena AK. Current status of tumor M2 pyruvate kinase(tumor M2-PK)as a biomarker of gastrointestinal malignancy[J]. Ann Surg Oncol, 2007, 14 (10): 2714-2720.
  • 10Feo S, Arcuri D, Piddini E, et al. EN01 gene produce binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein l[J]. FEBS Lett, 2000, 473 (1): 47-52.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部